- USDA Gets Tougher on Salmonella in Raw Breaded Chicken Products
- Fragments of Bird Flu Virus Found in 1 in 5 Milk Samples
- Clients Got HIV Through ‘Vampire Facial’ Microneedling Treatments
- Take the Stairs & Step Up to Longer Life
- ‘Drug Take Back Day’ is Saturday: Check for Leftover Opioids in Your Home
- Loneliness Can Shorten Lives of Cancer Survivors
- A Stolen Dog Feels Like Losing a Child, Study Finds
- Healthier Hearts in Middle Age Help Black Women’s Brains Stay Strong
- Better Scans Spot Hidden Inflammation in MS Patients
- Which Patients and Surgeries Are ‘High Risk’ for Seniors?
Mouse Study Hints at Which Brain Cells Trigger Fear
In experiments with mice, researchers say they have found cells in the brain that play a major role in triggering anxiety.
These cells are in a part of the brain called the hypothalamus, the scientists said.
To pinpoint these cells, the researchers blocked cells from getting the stress hormone called corticotropin-releasing hormone (CRH). CRH is a hormone involved in the body’s “fight-or-flight” response, the researchers explained.
Much to the researchers surprise, when CRH was blocked in some cells, anxiety behaviors such as vigilance, fear and suspicion were reduced, said one of the study’s authors, Rhong Zang. He’s with the division of Endocrinology at Boston Children’s Hospital.
Without the influence of CRH in these cells, mice were able to do things they normally feared, such as walking on elevated gangplanks, exploring brightly lit areas and approaching new objects.
Targeting these newly identified brain cells, instead of the entire brain, could lead to more effective treatment for anxiety disorders and perhaps other mental health problems, the researchers said.
However, blocking CRH production in just some brain cells would be challenging in humans, another of the study’s authors Dr. Joseph Majzoub, chief of the division of endocrinology, said in a hospital news release.
“Blocking just certain neurons releasing CRH would be enough to alter behavior in a major way,” he said.
“We don’t know how to do that, but at least we have a starting point,” he added.
Also, most research with animals fails to produce similar results in humans.
The researchers noted that up to 30 percent of Americans have clinical anxiety. They also said there’s a need for better treatments with fewer side effects.
The study was published Sept. 6 in the journal Molecular Psychiatry.
More information
The U.S. National Institute of Mental Health has more on anxiety disorders.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.